CA2075776A1 - Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen - Google Patents

Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen

Info

Publication number
CA2075776A1
CA2075776A1 CA002075776A CA2075776A CA2075776A1 CA 2075776 A1 CA2075776 A1 CA 2075776A1 CA 002075776 A CA002075776 A CA 002075776A CA 2075776 A CA2075776 A CA 2075776A CA 2075776 A1 CA2075776 A1 CA 2075776A1
Authority
CA
Canada
Prior art keywords
radical
formula
phenyl
ketoprofen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002075776A
Other languages
French (fr)
Inventor
Georg Schroeder
Dieter Arlt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2075776A1 publication Critical patent/CA2075776A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/12Ketones containing more than one keto group
    • C07C49/15Ketones containing more than one keto group containing rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Abstract of the Disclosure The invention relates to novel diastereomerically pure esters of ketoprofen of the formula:

Ia Ib (S-ketoprofen) (R-ketoprofen) (wherein:

R1 is in which R2 is alkyl, cycloalkyl, benzyl or phenyl;
Y is alkoxy, cycloalkoxy, benzyloxy, phenoxy or amino substituted by alkyl, cycloalkyl, benzyl or phenyl, or R1 is a group -

Description

2~7~';~.'{,`

The invention relateq to novel diastereomerically pure esters of ketoprofen, to processe~ for their preparation by asymmetric ketene addition ~nd to their use in the preparation of (R)- or (S)-ketoprofen.

Pharmacological properties of active ingredients very often depend on the ab~olute stereochemistry. This phenomenon has also been observed with nonsteroidal analgesics and antipyretics of the class of 2-aryl-propionic acids. For these reasons various methods for the preparation of enantiomerically pure carboxylic acids having a chiral ~-C atom have been developed.

The preparation of (S)- or (R)-ketoprofen by methods known to date gives only poor results. In the racemate separation of 2-(3-benzylphenyl)-propionic acid and also in the asymmetric hydrogenation of dehydroketoprofen using chiral rhodium catalysts, only poor yields are obtained, ju~t as i8 the case with oxidation to give (S)-ketoprofen (compare G. Comisso et al., Gazz. Chim.
Italia 110, 123 (1980)). Thi~ also applies to racemate separation of 2-(2-thiaxanthonyl)-propionic acids with subsequent multistage conversion to (S)-ketoprofen (compare US 3 641 127) and to direct racemate separation using phenethylamins (compare DE 3 824 353). Also, by chromatographic separation of the diastereomeric amides of ketoprofen with chiral amines, only small amounts of (S3-ketoprofen are obtainable following hydrolysis of the Le A 28 573 - 1 -Z~7;~776 amides (compare Abas et al., J. Pharmacol. Exp. Ther.
240, 637 ~1987)). Enzymatic e~tor hydroly~e~ also fail in the preparation of enantiomerically puro ketoprofon ~compare S.~. Wu ot al., J. Am. Chom. Soc., 112, 1990 (1990)).

In summary it can be ~aid that no suitable prep~ration processe~ are known to date for the industrial production of relatively large amounts of (S)- or (R)-ketoprofen.

It is further known to react activated racemic carboxylic acid derivatives with catalysis using chiral titanium complexes to give enantiomerically enriched esters (compare X. Narasaka et al., Chem. Lett. 1989, 1187).
These reactions have the advantage over classical racemate separation that they can in principle deliver yields greater than 50 %. US 4 691 020 and EP 390 273 further disclose additions of optically active alcohols ; and ~-hydroxyesters or ~-hydroxyamides ta certain ketenes, which lead to esters having diastereomeric ~; excesses.
' It is shown that the hitherto known and conventional methods for the separation of optical isomers of 2-aryl-propionic acids cannot be directly applied to ketoprofen.
`- Methods which can be used successfully, for example with the arylpropionic acid ibuprofen, fail when they are applied to ketoprofen or give only unsatisfactory yields.
In a comparison of the structures, those skilled in the art could infer that, in the ca~e of ketoprofen, Le A 28 573 - 2 -2 ~ S~7 ~
particularly difficult ~teric conditions are prosent.

It has surprisingly been fount that ~S)- and ~R)-keto-profen of the formulae Ia and Ib, respectively, ~ ~Y
o ~ OOH O
~ (St ~ ~ R) Ia Ib (S-ketoprofen) (R-ketoprofen) are obtained in a simple manner, in high purity and in good yields, if racemic ketoprofen of the formula Me COOH
~ (II) i9 reacted via the acid chloride in the preRence of tertiary amines to give ketenes of the general formula (III) : Me C=C=o ~ (III) Le A 28 573 - 3 -2~ 7fi this ketene is then transferred into a eeparate reaction vessel and i8 there reacted at temperatures between -100C and +25C with alcohols of the general formula (IV) Rl-OH (IV) in which IR~
Rl represents the -CH-CO-Y radical, where R~ represents a C~lO-alkyl radical, C3,-cycloalkyl 10radical, ben~yl or phenyl, and Y rapresents a C,10-alkoxy radical, a C3l0-cyclo-alkyloxy radical, benzyloxy or phenoxy, or Y represents an amine radical, which iB identi-cally or differently substituted by alkyl or cycloalkyl having up to 10 C atoms, benzyl or phenyl, or Rl represents a radical of the formula ~3 - x -CH - CO

Le A 28 573 - 4 -z ~7 Sq7 6 23189-7377 in which R~ repre~ent~ a C~,-alkylene radlcal, whlch 1 un~ubstituted or ~ubst~tuted by 1 or 2 C~O-alkyl group~, and X repre~ents oxygen or an imino group, which i~
substituted by C,l~-alkyl, benzyl or phenyl, to give di~stereomerically pure compounds of the general formulae (Va) and ~Vb) Me e COOR' ~ CoOR7 (S)-form (Va) or (R)-form (Vb) in the presence or ab~ence of inert organic salvent~ and the~e are then hydrolysed by conventional methods to give enantiomerically pure ketoprofen.

The invention al~o relateR to the diastereomerically pure esters of the formula (V), in which R' ha~ the meaning given above and to their u~e in the preparation of (R)-or (S)-ketoprofen.

The prepar~tion of the novel dia~tereomerically pure compounds according to the invention of the general Le A 28 573 - 5 -Z~!75~7~;
formula ~VI is preferably carried out ~tarting with the chloride of the acid of the formula (II) in the presence of a tertiary amine, in particular of an alkyl- or cyclo-alkylamine having in each cas~ up to 10 C atom~, in S particular having up to 6 C atoms, of a benzyl- or a phenylamine where the phenyl ring~ are unsubstituted or substituted by halogen, alkyl or alkoxy having up to 5 C
atoms, in a nonpolar solvent at temperatures between -80C and +25C with an optically active alcohol of the formula (IV), in which ~' has the meaning given above.

The hydrolysis of compounds of the general formula (V) to give the enantiomerically pure forms of ketoprofen is preferably carried out under basic conditions. The enantiomeric excess can be increased by conventional crystallisation processes.

Particularly preferred optically active alcohols of the general formula (IV) which can be mentioned are ~-hydroxyesters and u-hydroxyamides such as the isobutyl, ethyl, methyl, isopropyl and benzyl esters of lactic acid, or N,N-dimethyllactamide, and also ~-hydroxylactones or ~-hydroxyimides. The corresponding esters of the general formula (V) are likewise preferred.

Preferred tertiary amines for the reaction of the acid chlorides to give the ketenes are open-chain or cyclic trialkylamines. Particularly preferred amines are tri-(C~ 5)-alkylamine8 such as for axample trimethylamine, dimethylethylamine, triethyl~mine, 1,4-diaza-bicyclo-Le A 28 573 - 6 -Z3:~7 ~7~
t2,2,2]-octane (DABC0) or N-methylpyrrolidine.

The presence of the amine is not critical for the pre~ent process. The tertiary amine is preferably u3ed in a ratio of 0.01 to 10 molar equivalents relative to ketene (III), particularly preferably in a ratio of 0.01 to 2 molar equivalents of amine relative to ketene.

Suitable solvents for the reaction are aprotic liquids which are inert to the reactants. Examples of such solvents are hydrocarbons, such as for example hexane, heptane, toluene or cyclohexane, or ethers such as for example diethyl ether, tetrahydrofuran or tert-butyl methyl ether. Preferred solvents are hexane, heptane and toluene.

In the present process, the ~-hydroxyester or the ~-hydroxyamide is added to a solution of the ketene.
However, with larger batches, it can be a processing advantage to add the ketene (III) in solution to the ~-hydroxyester or ~-hydroxyamide.

The preparation of the ketene proceeds from the acid chlorides with the aid of the bases, in a nonpolar solvent, the solvent used expediently being that which is also used for the reaction of the ketene ~III), at temperatures between -20C and 50C, the ketene being formed immediately in a suitable reaction procedure and isolation being omitted. The amine hydrochlorides formed generally do not interfere in the subsequent reactions.

Le A 28 573 - 7 -2~7.~7~

The molar ratio of ketene ~II) to ~-hydroxye~ter or ~-hydroxyamide ~IV) can be 1 to 1.5, proferably 1 to 1.2.
Particular proference i8 given to the molar ratio of approximately 1:1. The proferred reaction temperature i~
in the range from -20C to -100C, but a temperature from -78C to -60C is particularly preferred. The u~able ketene concentration iB in a range from 1.0 M to 0.01 M.
The reaction mixture i8 stirred at the preferred temperature for 0.5 to 16 hour~. When the reaction is completed the diastereomeric esters are worked up and purified by standard processes and techniques, such as for example chromatography.

The corresponding diastereomeric esters (V) can be cleaved in a conventional manner, for example under acid conditions (see EP 0 179 487 or R. Lattrell et al., Ann.
Chem., 1974, 870) or under basic conditions (D.A. Evans et al., Tetrahedron Lett., 1987, 6141) or preferably under basic conditions in the LiOH/H2O/acetonitrile/
heptane/0C system (R.~. Larsen et al., J. Am. Chem.
Soc., 111, 7650 (1989)) to give the enantiomerically pure carboxylic acid ketoprofen, which is obtained with high enantiomeric excesses.

Examples The enantiomeric analysis was carried out by known methods ~for example according to EP 379 917) by chromatographic separation on chiral stationary phases.

Le A 28 573 - 8 -.

2r~7s776 Comparison Example A

Preparation of ethyl t(2S)-2-(3-benzoyl-phenyl)-pro-pionyl~-(SI-lactate by addition of the ethyl (S~-lactate to the ketene (conventional procedure) To a solution of 440.0 ml (4.02 mol) of N-ethyldimethyl-amine in 1740 ml of anhydrous toluene are added, in the course of 10 minutes, 366.5 g (1.34 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride at room temperature.
After completion of the addition, (R/S)-2-(3-ben~oyl-phenyl)-propionyl chloride could no longer be identified by means of IR spectroscopy. The resulting mixture i8 cooled to -78C, and a solution of 184.0 ml (1.64 mol) of ethyl (S)-lactate in 1740 ml of anhydrous toluene is added dropwise in the course of 30 min, the internal temperature not being allowed to exceed -70C. After completion of the addition, the mixture is stirred for a further 3 hours at -78C and i8 then slowly warmed to room temperature. 17.0 ml of 3-dimethylaminopropylA~;ne are then added, the mixture is stirred for 30 min at room temperature, washed with water, dried using magnesium sulphate and concentrated to dryness. The residue i~
purified by filtration on silica gel (ethyl acetate/
cyclohexane gradient 1/10 1 1/3 v/v). After concen-tration, a lightDyellow oil is obtained.
Yield: 45.49 g (9.6 % of theory) Diastereomer ratio (SS:RS) by GC analysis: 7.8:1 Le A 28 573 - 9 -.
~ . ~ , ..... .

Z0~5~7fi Example 1 Preparation of ethyl t(2S)-2-(3-benzoyl-phenyl)-pro-pionyl]-~S)-la¢tate by addition of the ketene to the ethyl (S)-lactate A solution of 118.8 ml (1.10 mol) of N-ethyl-dimethyl-amine in 200 ml of anhydrous toluene is added dropwise in the course of one hour in a cooled mixing chamber with stirring to 99.0 g (0.363 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride in 200 ml of toluene at room temperature. The suspension thus formed of ketene and amine hydrochloride is slowly added dropwise with stirring to a solution of 49.5 ml (0.44 mol) of ethyl (S)-lactate in 500 ml of anhydrous toluene and 40 ml (0.37 mol) of N-ethyl-dimethylamine, the internal temper-ature not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addition, the mixture is stirred for a further 3 hours at -78C and is then slowly warmed to room temperature. 4.6 ml of 3-dimethylaminopropylamine are then added, the mixture is stirred for 30 min at room temperature, washed with water, dried usinq magnesium sulphate and concentrated to dryness. ~he residue is purified by filtration on silica gel (ethyl acetate/cyclohexane gradient 1/10 1/3 v/v). After concentration, a light-yellow oil is obtained.
Yield: 84.98 g (65.4 ~ of theory) Diastereomer ratio (SS:RS) by GC analysis: 9.8:1 Le A 28 573 - 10 -z~,~7 ~7~;

H-NMR: (CDC13, 200 MHz) (S,S)-diasterooisomer:
- 1.15 (t, J ~ 7 Hz, 3H; -O-CH,-CH3), 1.47 (d, J - 7 Hz, 3H; -CH-CH3), 1.57 (d, J - 7 Hz, 3H; -CH-CH3), 3.87 (q, J ~ 7 Hz, lH; -CH-C~3), 4.10 (q, J - 7 Hz, 2H; -O-CH~-CH3), 5.08 (q, J ~ 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) (R,S)-diastereo~isomer 6 = 1.16 (t, J - 7 Hz, 3H; -O-CH~-CH3), 1.48 (d, J = 7 Hz, 3H; -CH-CH3), 1.58 (d, J s 7 Hz, 3H; -CH-CH3), 3.89 (q~ J s 7 Hz, lH; -CH-CH3), 4.10 (q, J - 7 Hz, 2H; -O-CH2-CH3), 5.08 (q, J s 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) MS: (CI, isobutane) m/e - 355 (M+H), 310 (4 %), 249 (6 %), 236 (6 %), 209 (16 ~), 105 (6 %) Exam~le 2 Preparation of ethyl ~(2S)-2-(3-benzoyl-phenyl)-pro-pionyl]-(S)-lactate by addition of the ketene to the lactate (concentrated reaction procedure) A solution of 591 ml (5.46 mol) of N-ethyl-dimethylamine in 500 ml of anhydrous toluene is added dropwiqe in the course of one hour in a cooled mixing chamber with stirring to 492.47 g (1.81 mol) of (R/S)-2-(3-benzoyl-Le A 28 573 - 11 -z~ j7~

phenyl)-propionyl chloride in 500 ml of toluene at room t~mperature, The suspension thus formed of keteno and amine hydrochloride is ~lowly added dropwise with stirring to a solution of 247 ml ~2.18 mol) of ethyl (S)-lactate in 1000 ml of anhydrou~ toluene and 197 ml (1.82 mol) of N-ethyldimethylamine, the internal temperature not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addi-tion, the mixture is stirred for a further 3 hours at -78C and is then 910wly warmed to room temperature. 4.6 ml of 3-dimethylaminopropylamine are then added, the mixture i~ stirred for 30 min at room temperature, washed with water, dried using magnesium sulphate and concentrated to dryness. The residue is purified by filtration on silica gel (ethyl acetate/cyclohexane gradient 1/10 . 1/3 v/v). After concentration, a light-yellow oil is obtained.

Yield: 436.98 g (68.0 % of theory) Diastereomer ratio (SS:RS) by GC analysis: 9.5:1 Preparation of (2S)-2-(3-benzoyl-phenyl)-propionic acid (ketoprofen) by basic hydrolysis A mixture of 436.98 g (1.234 mol) of ethyl [(2S)-2-(3-benzoyl-phenyl)-propionyl]-(S)-lactate (diastereomer ratio (SS:RS) by GC analysis: 9.5:1) in 237.95 g of lithium hydroxide, 2200 ml of water, 2360 ml of aceto-nitrile and 2360 ml of heptane is processed overnight with intensive stirring using a mechani cal sti rrer . The Le A 28 573 - 12 -2~:~7~7~' acetonitrile~water phase.is then separated and concentrated in vacuo at 25C
to remove the acetonitrile. The residue obtained is taken up in ethyl acetate and extracted with sodium hydroxide ~olution. The basic extract is acidified with hydrochloric acid and is extracted with ethyl acetate, dried and concentrated.

Yield: 300.91 g (1.185 mol) ~96.0 ~ of theory) Enantiomeric excess: 74.9 % (HPLC) ComParison Example B

Preparation of isobutyl ~(2R)-2-(3-benzoyl-phenyl)-propionyl3-(R)-lactate by addition of the isobutyl (R)-lactate to the ketene (conventional procedure) To a solution of 40.0 ml (0.370 mol) of N-ethyldimethyl-amine in 190 ml of anhydrous toluene are added in the course of one hour 49.83 g (0.183 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride at room temperature.
After completion of the addition, (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride could no longer be identified by means of IR spectroscopy. The resulting mixture is cooled to -78C, and a solution of 33.22 ml (0.220 mol) of isobutyl R-lactate in 190 ml of anhydrous toluene is added dropwise in the cour~e of 30 min, the internal temperature not being allowed to exceed -70C. After completion of the addition, the mixture is stirred for a further 3 hours at -78C and is then slowly warmed to room temperature. 2.5 ml of 3-dimethylaminopropylamine are then added, the mixture is stirred for 30 min at room Le A 28 573 - 13 -2~7 j~7~i temperature, washed with water, dried u~ing magnesium sulphate and concentrated to dryne~. The re-idue i~
purified by filtration on ~ilica gel (ethyl acetate/-cyclohexane gradient 1/10 1/3 v/v). After concen-tration, a light-yellow oil iB obtained.

Yield: 22.28 g ~58.10 mmol) ~31.7 ~ of theory) Diastereomer ratio (RR:SR) by GC analysis: 4.0~1 ExamDle 3 Preparation of isobutyl t(2R)-2-~3-benzoyl-phenyl)-propionyl3-(R)-lactate by addition of the ketene to the isobutyl (R)-lactate A solution of 150 ml (1.10 mol) of N-ethyl-dimethyl~m;ne in 240 ml of anhydrou~ toluene i8 added dropwise in the course of one hour in a cooled mixing chamber with stirring to 125.0 g (0.459 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride in 240 ml of toluene at room temperature. The suspension thus formed of ketene and amine hydrochloride is slowly added dropwise with stirring to a solution of 50.0 ml (0.44 mol) of i~obutyl (R)-lactate in 475 ml of anhydrous toluene and 150 ml (0.37 mol) of N-ethyldimethylamine, the internal tempera-ture not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addition, the mixture is stirred for a further 3 hours at -78C and i8 then slowly warmed to room temperature.
4.6 ml of 3-dimethylaminopropylamine are then added, the Le A 28 573 - 14 -2~757~
mixture i~ stirred for 30 min at room temperature, wa~hod with water, driod u~ing magne~ium eulphate and concen-trated to drynoss. The re~idue i~ purified by filtration on ~ilica gel ~ethyl acetato/cyclohexane gradient 1: 10 , 1/3 v/v) . Aftor concentration a light-yellow oil i~ obtained.

Yield: 113.77 g (0.30 mol) (65.4 % of theory) Dia~tereomer ratio (M:SR) by GC analy~ 9.8: 1 IH-NMR: (CDC13, 200 MHz) (S,S)-diastereoisomer:
6 -- 0.85 (d, J -- 7 Hz, 6H; -CH-(CH3)2), 1.49 ( d , J -- 7 Hz , 3H ; -CH-CH3), 1.57 (d, J - 7 Hz, 3H; -CH-CH3), 1.83 (mc, lH; -CH2-CH-(CH3),), 3.85 (d, 2H, J -- 7 Hz; -CH2-CH-), 3.89 (q, J -- 7 Hz, lH; -CH-CH3), 5.11 (q, J = 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H, arom. H) (S,R) -di astereoi somer ~ ~ 0.92 (d, J ~ 7 Hz, 6H; -CH-(CH3)2), 1.46 (d, J -- 7 Hz, 3H; -CH-CH3), 1.54 (d, J - 7 Hz, 3H; -CH-CH3), 1.83 (mc, lH; -CH2-CH-(CH3)2), 3.85 (d, 2H, 7 Hz, -CH2-CH-), 3.89 (g, J -- 7 Hz, lH; -CH-CH3), 5.11 (q, J - 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) Le A 28 573 - 15 -X~ ~ 7~;

MS: (C~, isobutane) m/o - 383 (M+H), (lO0 %, M+H), 3.27 (14 %), 209 (20 %), 105 (8 %) Preparation of (2~)-2 (3-benzoyl-phenyl)-propionic acid (ketoprofen) by ba~ic hydrolysiQ

S A mixture of 113.77 g (0.297 mol) of isobutyl [(2R)-2-(3-benzoyl-phenyl)-propionyl]-(R)-lactate (diastereomer ratio (RR:SR) by GC analysis: 9.8:1) in 57.49 g of lithium hydroxide, 525 ml of water, 570 ml of aceto-nitrile and 570 ml of heptane is processed overnight with intensive stirring using a mechanical stirrer. The acetonitrile/water phase is then separated and concentrated in vacuo at 25C to r~ve the acetonitrile. The resid~
obtained i3 taken up in ethyl acetate and extracted with sodium hydroxide solution. The basic extract is acidified with hydrochloric acid and extracted with ethyl acetate, dried and concentrated.

Yield: 67.14 g (0.264 mol) (89.0 % of theory) Enantiomeric excess: 74.0 % (HPLC) Le A 28 5?3 - 16 -

Claims (8)

1. Diastereomerically pure compounds of the general formulae (Va) and (Vb) (S)-form (Va) or (R)-form (Vb) in which R1 represents the radical, where R2 represents a C1-10-alkyl radical, C3-5-cycloalkyl radical, benzyl or phenyl, and Y represents a C1-10-alkoxy radical, a C3-10-cycloalkyloxy radical, benzyloxy or phenoxy, or Y represents an amine radical, which is identically or differently substituted by alkyl or cycloalkyl having up to 10 C

Le A 28 573 - 17 -atoms, benzyl or phenyl, or R1 represents a radical of the formula in which R3 represents a C2-4-alkylene radical, which is unsubstituted or substituted by 1 or 2 C1-10alkyl groups, and X represents oxygen or an imino group, which is substituted by C1-10-alkyl, benzyl or phenyl.
2. Process for the preparation of compounds of the general formula (V) according to Claim 1, charac-terised in that racemic ketoprofen of the formula (II) (II) is reacted via the acid chloride in the presence of a tertiary amine to give a ketene of the general Le A 28 573 - 18 -formula (III) (III) this ketene is then transferred into a separate reaction vessel and is there reacted at temperatures between -100°C and +25°C with an alcohol of the general formula (IV) R1-OH (IV) in which R1 has the meaning given in Claim 1, to give diastereomerically pure compounds of the general formulae (Va) and (Vb) (S)-form (Va) or (R)-form (Vb) in the presence or absence of inert organic solvents.
3. Use of compounds of the general formula (V) accord-ing to Claim 1 for the preparation of (R)- or (S)-ketoprofen.
4. Process for the preparation of (R)- and (S)-keto-profen, characterised in that diasteromerically pure esters of the general formula (V) according to Claim 1 are hydrolysed by conventional methods.

Le A 28 573 - 19 -
5. Process according to Claim 4, characterised in that the hydrolysis is carried out under basic conditions.
6. Process according to Claim 2, wherein the alcohol of the formula R1-OH (IV) is an alpha-hydroxylactone or alpha-hydroxyimide of the formula:

(wherein R3 represents a C2-4 alkylene radical which is un-substituted or substituted by one or two C1-10 alkyl groups, and X represents oxygen or an imino group which is substituted by C1-10 alkyl, benzyl or phenyl).
7. The process according to Claim 2, wherein the alcohol of the formula R1-OH (IV) is a lactate.
8. The compound according to Claim 1, wherein R2 is ethyl and Y is C1-10 alkoxy, C3-10 cycloalkoxy, benzyloxy or phenoxy.
CA002075776A 1991-08-14 1992-08-11 Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen Abandoned CA2075776A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4126859A DE4126859A1 (en) 1991-08-14 1991-08-14 DIASTEREOMERIC INTERMEDIATE PRODUCTS AND THEIR USE IN THE PRODUCTION OF (R) - OR (S) -KETOPROFENS
DEP4126859.8 1991-08-14

Publications (1)

Publication Number Publication Date
CA2075776A1 true CA2075776A1 (en) 1993-02-15

Family

ID=6438275

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002075776A Abandoned CA2075776A1 (en) 1991-08-14 1992-08-11 Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen

Country Status (7)

Country Link
EP (1) EP0531700A3 (en)
JP (1) JPH05262697A (en)
KR (1) KR930004244A (en)
CA (1) CA2075776A1 (en)
DE (1) DE4126859A1 (en)
FI (1) FI923617A (en)
HU (1) HUT62252A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808069A (en) * 1993-03-09 1998-09-15 Dompe' Farmaceutici Spa Salts of 2-(3-benzoylphenyl) propionic acid with organic bases and pharmaceutical compositions thereof
WO2003089448A1 (en) * 2002-04-22 2003-10-30 Hualu Wang Ibuprofen ribavirin ester, its method of preparation and use
JP4830435B2 (en) * 2005-09-30 2011-12-07 大日本印刷株式会社 Photosensitive resin composition and article
JP5152350B2 (en) * 2011-01-17 2013-02-27 大日本印刷株式会社 Photosensitive resin composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940813A (en) * 1989-03-31 1990-07-10 Merck & Co., Inc. Resolution of a carboxylic acid

Also Published As

Publication number Publication date
HU9202628D0 (en) 1992-10-28
HUT62252A (en) 1993-04-28
EP0531700A2 (en) 1993-03-17
DE4126859A1 (en) 1993-02-18
KR930004244A (en) 1993-03-22
EP0531700A3 (en) 1993-04-14
FI923617A0 (en) 1992-08-12
FI923617A (en) 1993-02-15
JPH05262697A (en) 1993-10-12

Similar Documents

Publication Publication Date Title
JP3171931B2 (en) (R)-(-)-4-cyano-3-hydroxybutyric acid t-butyl ester and method for producing the same
KR100758620B1 (en) 4-Alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
US6552204B1 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
CA2075776A1 (en) Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen
KR20040084915A (en) Novel boronate esters
US6403804B1 (en) Process for preparing optically active oxazolidinone derivative
JP5094392B2 (en) Process for producing optically active 2-hydroxybutyric acid ester
JP5094397B2 (en) Method for producing optically active ester
JP4043810B2 (en) Process for producing optically active 3-chlorocarboxylic acid ester
JP3766463B2 (en) Process for producing enantiomers of 2- (2-fluoro-4-biphenyl) propionic acid
JP2691363B2 (en) Process for producing optically active 3,4-dihydroxybutyric acid derivative
JP5329462B2 (en) Optically active dicarboxylic acid derivative
US6667422B2 (en) Process for the preparation of α-haloketones
JP5796762B2 (en) Method for producing optically active cyclohexene derivative
WO2021161101A1 (en) Preparation of s-beflubutamid by resolving 2-(4-fluoro-3-(trifluoromethyl)phenoxy)butanoic acid
JP3879141B2 (en) Cyclic ester compound and method for producing the same
JPH04295469A (en) Method of manufacturing optically active ester of quinoxalinyloxyphenoxypropionic acid
JP4958513B2 (en) Method for producing sedanenolide
JPH1045721A (en) Production of 1-substituted-4,5-diphenyl-2-imidazolidinone and intermediate for the same
JP2002226472A (en) Amino- and hydroxyfuranone containing one enantiomer richly
JPH10509174A (en) Efficient process for producing N-substituted dehydroamino acid esters
JPH09176130A (en) Optically active 4,5-diphenyl-2-imidazolidinone derivative
JP2004067577A (en) Method for producing thienyl ketoester
JPH09208514A (en) Production of optically active carboxylic acids
JPH10101640A (en) New thioester

Legal Events

Date Code Title Description
FZDE Discontinued